Works by Shimizu, Takuto

Results: 55
    1

    Immunosuppressant-Induced Alteration of Gut Microbiota Causes Loss of Skeletal Muscle Mass: Evidence from Animal Experiments Using Mice and Observational Study on Humans.

    Published in:
    Journal of Clinical Medicine, 2025, v. 14, n. 5, p. 1628, doi. 10.3390/jcm14051628
    By:
    • Tomizawa, Mitsuru;
    • Hori, Shunta;
    • Yoneda, Tatsuo;
    • Maesaka, Fumisato;
    • Onishi, Sayuri;
    • Shimizu, Takuto;
    • Onishi, Kenta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Miyake, Makito;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    2

    The novel sustained 3‐hydroxybutyrate donor poly‐D‐3‐hydroxybutyric acid prevents inflammatory bowel disease through upregulation of regulatory T‐cells.

    Published in:
    FASEB Journal, 2023, v. 37, n. 1, p. 1, doi. 10.1096/fj.202200919R
    By:
    • Suzuki, Rimina;
    • Mishima, Mayuko;
    • Nagane, Masaki;
    • Mizugaki, Hinano;
    • Suzuki, Takehito;
    • Komuro, Mariko;
    • Shimizu, Takuto;
    • Fukuyama, Tomoki;
    • Takeda, Shiro;
    • Ogata, Masaya;
    • Miyamoto, Takayoshi;
    • Aihara, Naoyuki;
    • Kamiie, Junichi;
    • Kamisuki, Shinji;
    • Yokaryo, Hiroto;
    • Yamashita, Tadashi;
    • Satoh, Takumi
    Publication type:
    Article
    3

    Initial experience of complete laparoscopic radical nephroureterectomy combined with transvesical laparoscopic excision of distal ureter in patients with upper urinary tract cancer.

    Published in:
    World Journal of Surgical Oncology, 2020, v. 18, n. 1, p. 1, doi. 10.1186/s12957-020-01872-1
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Aoki, Katsuya;
    • Ohmori, Chihiro;
    • Shimizu, Takuto;
    • Owari, Takuya;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Anai, Satoshi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    4
    5

    Supplementary granulocyte macrophage colony‐stimulating factor to chemotherapy and programmed death‐ligand 1 blockade decreases local recurrence after surgery in bladder cancer.

    Published in:
    Cancer Science, 2019, v. 110, n. 10, p. 3315, doi. 10.1111/cas.14158
    By:
    • Miyake, Makito;
    • Hori, Shunta;
    • Ohnishi, Sayuri;
    • Toritsuka, Michihiro;
    • Fujii, Tomomi;
    • Shimizu, Takuto;
    • Owari, Takuya;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Itami, Yoshitaka;
    • Nakai, Yasushi;
    • Anai, Satoshi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    6

    Association between urine 6-sulfatoxy-melatonin level and intravesical Bacillus Calmette-Guerin treatment-induced sleep quality deterioration in patients with non-muscle invasive bladder cancer.

    Published in:
    Supportive Care in Cancer, 2022, v. 30, n. 7, p. 6145, doi. 10.1007/s00520-022-07043-0
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Ohnishi, Sayuri;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Shimizu, Takuto;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Anai, Satoshi;
    • Torimoto, Kazumasa;
    • Aoki, Katsuya;
    • Fujii, Tomomi;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    7

    Clinical relevance of Nectin-4 downregulation and biological changes caused by cytotoxic chemotherapy in bladder cancer.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2025, v. 95, n. 1, p. 1, doi. 10.1007/s00280-025-04783-8
    By:
    • Miyake, Makito;
    • Owari, Takuya;
    • Iida, Kota;
    • Onishi, Sayuri;
    • Nishimura, Nobutaka;
    • Fujii, Tomomi;
    • Jinno, Cynthia N.;
    • Furuya, Hideki;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Onishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Goto, Daisuke;
    • Nakai, Yasushi;
    • Tanaka, Nobumichi;
    • Miura, Noriyoshi;
    • Kikugawa, Tadahiko
    Publication type:
    Article
    8

    A Multicenter, Single-Arm, Prospective Trial to Evaluate Efficacy and Safety of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Carboplatin (DD-MVACarbo) Chemotherapy for Cisplatin-Ineligible Patients with Advanced Urothelial Cancer: Study Protocol of the CARBUNCLE Trial

    Published in:
    Methods & Protocols, 2024, v. 7, n. 4, p. 58, doi. 10.3390/mps7040058
    By:
    • Miyake, Makito;
    • Anai, Satoshi;
    • Iemura, Yusuke;
    • Ichikawa, Kazuki;
    • Miyamoto, Tatsuki;
    • Tomioka, Atsushi;
    • Kuwada, Masaomi;
    • Itami, Yoshitaka;
    • Hosokawa, Yukinari;
    • Matsumura, Yoshiaki;
    • Okajima, Eijiro;
    • Torimoto, Kazumasa;
    • Nishimura, Nobutaka;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    9
    10
    11

    Longitudinal assessment of health-related quality of life in Japanese patients with advanced urothelial carcinoma receiving immune check point inhibitors.

    Published in:
    Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-72755-8
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Iida, Kota;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Owari, Takuya;
    • Ohnishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Fujii, Tomomi;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    12

    Dysgeusia in patients with advanced urothelial carcinoma receiving enfortumab vedotin, platinum-based chemotherapy, or immune check point inhibitors: time-course assessment using chemotherapy-induced taste alteration scale.

    Published in:
    Journal of Chemotherapy (Taylor & Francis Ltd), 2025, v. 37, n. 2, p. 146, doi. 10.1080/1120009X.2024.2340885
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Fujii, Tomomi;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    13
    14
    15

    Long‐term follow‐up of congenital hydronephrosis in a single‐center study.

    Published in:
    International Journal of Urology, 2024, v. 31, n. 5, p. 507, doi. 10.1111/iju.15391
    By:
    • Morizawa, Yosuke;
    • Aoki, Katsuya;
    • Fukui, Shinji;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Onishi, Kenta;
    • Hori, Shunta;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Miyake, Makito;
    • Torimoto, Kazumasa;
    • Fujimoto, Ken;
    • Otani, Takeshi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    16
    17
    18

    Clinical significance of limited and extended pelvic lymph node dissection during robot‐assisted radical prostatectomy for patients with localized prostate cancer: A retrospective, propensity score matching analysis.

    Published in:
    International Journal of Urology, 2023, v. 30, n. 2, p. 168, doi. 10.1111/iju.15075
    By:
    • Hori, Shunta;
    • Nakai, Yasushi;
    • Tachibana, Akira;
    • Omori, Chihiro;
    • Nishimura, Nobutaka;
    • Inoue, Kuniaki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Miyake, Makito;
    • Torimoto, Kazumasa;
    • Yoneda, Tatsuo;
    • Fujimoto, Kiyohide;
    • Tanaka, Nobumichi
    Publication type:
    Article
    19
    20

    Trends in risk classification at diagnosis and choice of primary therapy for prostate cancer: An analysis of 10 839 patients from the Nara Urological Research and Treatment Group registry between 2004 and 2015.

    Published in:
    International Journal of Urology, 2021, v. 28, n. 11, p. 1164, doi. 10.1111/iju.14666
    By:
    • Nakai, Yasushi;
    • Tanaka, Nobumichi;
    • Fujii, Tomomi;
    • Miyake, Makito;
    • Anai, Satoshi;
    • Hori, Shunta;
    • Shimizu, Takuto;
    • Onishi, Mikiko;
    • Ichikawa, Kazuki;
    • Onishi, Kenta;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    21

    Clinical benefit of early treatment with bone‐modifying agents for preventing skeletal‐related events in patients with genitourinary cancer with bone metastasis: A multi‐institutional retrospective study.

    Published in:
    International Journal of Urology, 2019, v. 26, n. 6, p. 630, doi. 10.1111/iju.13939
    By:
    • Owari, Takuya;
    • Miyake, Makito;
    • Nakai, Yasushi;
    • Hori, Shunta;
    • Tomizawa, Mitsuru;
    • Ichikawa, Kazuki;
    • Shimizu, Takuto;
    • Iida, Kota;
    • Samma, Shoji;
    • Iemura, Yusuke;
    • Momose, Hitoshi;
    • Omori, Chihiro;
    • Otani, Takeshi;
    • Kuwada, Masaomi;
    • Hirao, Shuya;
    • Oyama, Nobuo;
    • Nakagawa, Yoshinori;
    • Hayashi, Yoshiki;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    22
    23
    24
    25

    Photodynamic Therapeutic Effect during 5‐Aminolevulinic Acid‐Mediated Photodynamic Diagnosis‐Assisted Transurethral Resection of Bladder Tumors.

    Published in:
    Advances in Urology, 2024, v. 2024, p. 1, doi. 10.1155/2024/7548001
    By:
    • Nishimura, Nobutaka;
    • Miyake, Makito;
    • Onishi, Sayuri;
    • Fujii, Tomomi;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Morizawa, Yosuke;
    • Hori, Shunta;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide;
    • Zhou, Xuelin
    Publication type:
    Article
    26
    27
    28

    Comparison of Post‐Radical Cystectomy Renal Function and Ileal Conduit‐Related Complications Between Extracorporeal and Robot‐Assisted Intracorporeal Urinary Diversion: A Single‐Center Experience.

    Published in:
    Asian Journal of Endoscopic Surgery, 2025, v. 18, n. 1, p. 1, doi. 10.1111/ases.70033
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Owari, Takuya;
    • Iida, Kota;
    • Ohnishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Inoue, Takeshi;
    • Anai, Satoshi;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    29

    Clinical impact of the intensity of follow-up cystoscopy in patients with high-risk non-muscle-invasive bladder cancer.

    Published in:
    International Urology & Nephrology, 2024, v. 56, n. 3, p. 827, doi. 10.1007/s11255-023-03851-3
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Nishioka, Yuichi;
    • Fujii, Tomomi;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Owari, Takuya;
    • Ohnishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Imamura, Tomoaki;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    30
    31
    32
    33

    Enfortumab vedotin following platinum-based chemotherapy and immune checkpoint inhibitors for advanced urothelial carcinoma: response, survival and safety analysis from a multicentre real-world Japanese cohort.

    Published in:
    Japanese Journal of Clinical Oncology, 2024, v. 54, n. 3, p. 329, doi. 10.1093/jjco/hyad170
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Ohmori, Chihiro;
    • Takamatsu, Norimi;
    • Itami, Yoshitaka;
    • Tachibana, Akira;
    • Matsumoto, Yoshihiro;
    • Kiba, Keisuke;
    • Tomioka, Atsushi;
    • Yamamoto, Hiroaki;
    • Okajima, Eijiro;
    • Masaomi, Kuwata;
    • Sakamoto, Keichi;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Ohnishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke
    Publication type:
    Article
    34

    Clinical practice of UroVysion® urine test in patients with bladder carcinoma in situ treated with intravesical Bacillus Calmette–Guerin.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 7, p. 629, doi. 10.1093/jjco/hyad029
    By:
    • Miyake, Makito;
    • Hori, Shunta;
    • Fujii, Tomomi;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Ohnishi, Kenta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    35

    The Japanese health care system-based cost-effectiveness of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 4, p. 343, doi. 10.1093/jjco/hyac203
    By:
    • Nishimura, Nobutaka;
    • Miyake, Makito;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Morizawa, Yosuke;
    • Hori, Shunta;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    36

    Switch-maintenance avelumab immunotherapy following first-line chemotherapy for patients with advanced, unresectable or metastatic urothelial carcinoma: the first Japanese real-world evidence from a multicenter study.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 3, p. 253, doi. 10.1093/jjco/hyac186
    By:
    • Miyake, Makito;
    • Shimizu, Takuto;
    • Oda, Yuki;
    • Tachibana, Akira;
    • Ohmori, Chihiro;
    • Itami, Yoshitaka;
    • Kiba, Keisuke;
    • Tomioka, Atsushi;
    • Yamamoto, Hiroaki;
    • Ohnishi, Kenta;
    • Nishimura, Nobutaka;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Fujii, Tomomi;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    37

    Significant Improvement of Prognosis After the Advent of Immune Checkpoint Inhibitors in Patients with Advanced, Unresectable, or Metastatic Urothelial Carcinoma: A Propensity Score Matching and Inverse Probability of Treatment Weighting Analysis on Real-World Data

    Published in:
    Cancer Management & Research, 2022, v. 14, p. 623, doi. 10.2147/CMAR.S348899
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Shimizu, Takuto;
    • Ohnishi, Mikiko;
    • Kuwada, Masaomi;
    • Itami, Yoshitaka;
    • Inoue, Takeshi;
    • Ohnishi, Kenta;
    • Matsumoto, Yoshihiro;
    • Yoshida, Takanori;
    • Tatsumi, Yoshihiro;
    • Shinohara, Masatake;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Anai, Satoshi;
    • Torimoto, Kazumasa;
    • Aoki, Katsuya;
    • Fujii, Tomomi
    Publication type:
    Article
    38

    Difference of oncological efficacy between two immune checkpoint inhibitors following first-line platinum-based chemotherapy in patients with unresectable, metastatic, advanced urothelial carcinoma: a multicenter real-world Japanese cohort.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 9, p. 1311, doi. 10.1007/s10147-024-02573-5
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Iida, Kota;
    • Inoue, Kuniaki;
    • Tachibana, Akira;
    • Yoshikawa, Takanosuke;
    • Sakamoto, Keichi;
    • Ohnishi, Mikiko;
    • Maesaka, Fumisato;
    • Takamatsu, Norimi;
    • Mieda, Kosuke;
    • Ohmori, Chihiro;
    • Matsubara, Toshihiko;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Ohnishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke
    Publication type:
    Article
    39

    First-line pembrolizumab for patients with early relapsing urothelial carcinoma after perioperative chemotherapy: a retrospective analysis of bladder cancer and upper urinary tract cancer.

    Published in:
    International Journal of Clinical Oncology, 2022, v. 27, n. 11, p. 1733, doi. 10.1007/s10147-022-02230-9
    By:
    • Nishimura, Nobutaka;
    • Miyake, Makito;
    • Shimizu, Takuto;
    • Matsubara, Toshihiko;
    • Miyamoto, Tatsuki;
    • Sakamoto, Keichi;
    • Yamada, Atsushi;
    • Matsumoto, Yoshihiro;
    • Yoshikawa, Motokiyo;
    • Ichikawa, Kazuki;
    • Omori, Chihiro;
    • Maesaka, Fumisato;
    • Oda, Yuki;
    • Kiba, Keisuke;
    • Tomioka, Atsushi;
    • Hosokawa, Yukinari;
    • Tanaka, Masahiro;
    • Otani, Takeshi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    40
    41
    42

    Impact of Complete Surgical Resection of Metastatic Lesions in Patients with Advanced Renal Cell Carcinoma in the Era of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors.

    Published in:
    Cancers, 2024, v. 16, n. 4, p. 841, doi. 10.3390/cancers16040841
    By:
    • Shimizu, Takuto;
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Yoshida, Takanori;
    • Itami, Yoshitaka;
    • Tachibana, Akira;
    • Omori, Chihiro;
    • Oda, Yuki;
    • Kohashi, Mikiko;
    • Tomizawa, Mitsuru;
    • Onishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Dotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    43

    Organ-Specific and Mixed Responses to Pembrolizumab in Patients with Unresectable or Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study.

    Published in:
    Cancers, 2022, v. 14, n. 7, p. 1735, doi. 10.3390/cancers14071735
    By:
    • Shimizu, Takuto;
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Inoue, Kuniaki;
    • Fujii, Koyo;
    • Iemura, Yusuke;
    • Ichikawa, Kazuki;
    • Omori, Chihiro;
    • Tomizawa, Mitsuru;
    • Maesaka, Fumisato;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Sakamoto, Keiichi;
    • Kiba, Keisuke;
    • Tanaka, Masahiro;
    • Oyama, Nobuo;
    • Okajima, Eijiro;
    • Fujimoto, Ken;
    • Hori, Shunta;
    • Morizawa, Yosuke
    Publication type:
    Article
    44

    Intravesical Bacillus Calmette–Guérin Treatment for T1 High-Grade Non-Muscle Invasive Bladder Cancer with Divergent Differentiation or Variant Morphologies.

    Published in:
    Cancers, 2021, v. 13, n. 11, p. 2615, doi. 10.3390/cancers13112615
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Iida, Kota;
    • Fujii, Tomomi;
    • Nishikawa, Ryoma;
    • Teraoka, Shogo;
    • Takenaka, Atsushi;
    • Kikuchi, Hiroshi;
    • Abe, Takashige;
    • Shinohara, Nobuo;
    • Okajima, Eijiro;
    • Shimizu, Takuto;
    • Hori, Shunta;
    • Tsuchiya, Norihiko;
    • Owari, Takuya;
    • Murakami, Yasukiyo;
    • Taoka, Rikiya;
    • Kobayashi, Takashi;
    • Kojima, Takahiro;
    • Nishiyama, Naotaka
    Publication type:
    Article
    45

    Successful salvage of allograft dysfunction triggered by transplant renal vein thrombosis immediately after kidney transplantation: a case report.

    Published in:
    International Journal of Nephrology & Renovascular Disease, 2018, v. 11, p. 321, doi. 10.2147/IJNRD.S185520
    By:
    • Hori, Shunta;
    • Miyamoto, Tatsuki;
    • Sakamoto, Keiichi;
    • Shimizu, Takuto;
    • Ichikawa, Kazuki;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Miyake, Makito;
    • Yoneda, Tatsuo;
    • Tanaka, Nobumichi;
    • Yoshida, Katsunori;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    46
    47
    48
    49
    50